UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...
The groundbreaking study ... Face-Conforming LED Mask Showing 340% Improved Efficacy in Deep Skin Elasticity Oct. 29, 2024 — A research team has developed a deep skin-stimulating LED mask which ...